Abstract
Studies directed toward the oxidative and reductive desulfurization of readily available 2'-S-aryl-2'-thiouridine derivatives were investigated with the prospect to functionalize the C2'-position of nucleosides. The oxidative desulfurization-difluorination strategy was successful on 2-(arylthio)alkanoate surrogates, while extension of the combination of oxidants and fluoride sources was not an efficient fluorination protocol when applied to 2'-S-aryl-2'-thiouridine derivatives, resulting mainly in C5-halogenation of the pyrimidine ring and C2'-monofluorination without desulfurization. Cyclic voltammetry of 2'-arylsulfonyl-2'-deoxyuridines and their 2'-fluorinated analogues showed that cleavage of the arylsulfone moiety could occur, although at relatively high cathodic potentials. While reductive-desulfonylation of 2'-arylsulfonyl-2'-deoxyuridines with organic electron donors (OEDs) gave predominantly base-induced furan type products, chemical (OED) and electrochemical reductive-desulfonylation of the α-fluorosulfone derivatives yielded the 2'-deoxy-2'-fluorouridine and 2',3'-didehydro-2',3'-dideoxy-2'-fluorouridine derivatives. These results provided good evidence of the generation of a C2'-anion through carbon-sulfur bond cleavage, opening new horizons for the reductive-functionalization approaches in nucleosides.
Keywords: Cyclic Voltammetry, Desulfurization-Fluorination, Fluorination, Nucleosides, Organic Electron Donors, Reductive Desulfonylation
Introduction
Introduction of fluorine atom(s) into nucleosides dramatically changes their electronic and steric properties, giving them a wide range of biological activity.1-3 Prominent examples of C2' fluorinated nucleosides with potent biological activities include anticancer drugs gemcitabine,4-6 and clofarabine;7,8 and hepatitis C virus drug sofosbuvir.9,10 In the last 40 years, numerous methods for the incorporation of fluorine atoms into organic molecules have been developed, as summarized in excellent reviews.11-16 Despite these developments, construction of the tertiary fluorinated stereocenter at the sugar C2' (e.g. sofosbuvir) has been still challenging.17
Oxidative desulfurization-(di)fluorination is an important fluorination protocol for the preparation of fluoro organic compounds.16,18 Various reagents or reagent-combinations developed for this approach are known and are based mostly on the combination of an oxidant [e.g., N-halosuccinimides (NBS, NIS) or 1,3-dibromo-5,5-dimethylhydantoin (DBH)] and a potentially hazardous fluoride source [e.g., HF-pyridine,19-21 iodine pentafluoride (IF5),22-24 air- and moisture-stable IF5-pyridine-HF reagent,25,26 or BrF3-KHF2].27 In addition to these chemical approaches, direct and indirect (with the use of a redox mediator) electrochemical approaches have been developed for some oxidative desulfurization-(di)fluorination reactions, using different sources of fluorinating reagents, either in organic solvents or in Ionic Liquids (ILs).28-31
Although, chemical and electrochemical-induced reductive desulfonylation reactions have been known for years,32-40 in nucleosides they have been limited to reductive dehalogenation or desulfonylation protocols en route to 2',3'-dideoxy-2',3'-didehydro nucleosides.41-47 Reductive desulfonylation/functionalization (including (di)fluorination) strategies in nucleosides are to the best of our knowledge, unknown processes. Our goal was to investigate alternative methodologies for the modification of nucleosides at C2' position utilizing 2'-S-aryl-2'-thionucleosides as convenient substrates to access well-known fluoro nucleosides (e.g., gemcitabine or PSI 6130, a core of Sofosbuvir). Herein we report studies on the reactivity of 2'-S-aryl-2'-thiouridine substrates (type I, Figure 1) with respect to oxidation processes and 2'-arylsulfonyl-2'-deoxyuridine (type II) with respect to reductive processes. The oxidative fluorination processes are envisioned to proceed via desulfurization-difluorination of the uridine-2'-thioethers (substrate I, X = H) or desulfurization-fluorination of uridine α-fluorothioethers (substrate I, X = F) using halonium ion (Br+, I+) reagents as oxidants and a nucleophilic fluorine source (F−) for quenching the intermediary C2'-carbocation. The reductive fluorination processes are proposed to proceed via cleavage of the sulfonyl moiety (from substrate II, X = H or F) with single electron transfer reagents or electrochemically and quenching the resultant C2'-carbanion with electrophiles such as F+, H+, CH3, etc.
Figure 1.
Proposed pathways for the C2'-functionalization of uridine derivatives
Results and Discussion
Because of the lack of examples for desulfurization-difluorination reactions of aryl-alkyl thioethers with the arylthio group attached to a secondary internal carbon atom, we initially performed model studies with α-arylthio substituted esters (e.g., 2; Scheme 1) that mimic the 2'-postion of the ribose in the nucleoside targets (e.g., I, X = H). Using the methodology developed by Haufe et al.20,21 we found that treatment of ethyl 2-(phenylthio)octanoate 2 with DBH (3 eq.) and Olah’s reagent (Py.9HF, 6 eq.) in CH2Cl2 at 35°C for 2 h, showed 90% conversion to 2,2-difluorooctanoate 5b (1H NMR, 19F NMR; Scheme 1). The para-chlorophenylthio substituted ester 3 provided 2,2-difluorohexanoate 5a in almost quantitative yield in only 1 h, whereas para-methoxyphenylthio ester 4 required 16 h to show 70% conversion to 5a.48 These results illustrated that 4-chlorophenyl thioethers were better substrates for these difluorination reactions than corresponding phenyl and 4-methoxyphenyl thioethers, as noted also by Haufe, et al. for the primary alkyl-aryl thioethers.21 The EDGs on the phenyl ring are believed to stabilize the cationic charge on the resonance-stabilized carbenium-sulfonium ion intermediate and thus promote the first fluorination step; whereas EWGs are assumed to ease the elimination of arylsulfenyl bromide in the last step and therefore promote the critical second fluorination step.21 The DBH was proven to be more effective than other halogen oxidants (NBS, NIS) in these reactions.48
Scheme 1.
Desulfurization-difluorinations of α-thioesters 2-4.
Despite successful desulfurization-difluorination strategy with 2-arylthioalkanoate surrogates, our attempts to extend this protocol to sugars and nucleosides met with only limited success. Thus, treatment of (S)-(+)-2-phenylthio-4-benzyloxymethyl-4-butanolide49 with DBH (4 equiv.)/Py.9HF (8 equiv.)/CH2Cl2/35 °C/15 h gave complex reaction mixture.48 Also, attempted fluorination of readily available50 2'-S-aryl-2'-thiouridine analogues of type 651 (Scheme 2) or 2'-S-aryl-2'-fluoro-2'-thiouridine analogues of type 851 (Scheme 3) with Py.9HF/DBH failed to give 2',2'-difluoro products yielding instead 5-brominated52 products as well as the corresponding sulfoxides and/or α-fluoro sulfoxides, among other byproducts. Installing different protection groups on sugar hydroxyls (Ac, Bn) and EDG (MeO) or EWG (Cl) in phenyl ring as well as changing reaction conditions (e.g., halogen source, temperature, reaction time) did not change the outcome.48
Scheme 2.
Attempted fluorination of 2'-S-(4-methoxyphenyl)-2'-thiouridine analogue 6
Conditions A: NIS (2.1 eq), Py.9HF (3 eq); Conditions B: NIS (2.1 eq), DAST (6 eq).
Scheme 3.

Attempted fluorination of 2'-fluoro-2'-S-(4-methoxyphenyl)-2'-thiouridine derivative 8
Interestingly, treatment of the 4-methoxyphenyl thioether 6 with NIS (2.1 eq.)/Py.9HF (3 eq.) gave the corresponding 5-iodo 7 (29%) and the α-fluorothioether 8 (12%) products (Scheme 2). Analogous treatment of sulfide 6 with NIS/DAST combination53,54 produced the mono-α-fluorothioether 8 in 44% isolated yield without 5-halogenation. In contrast, treatment of 6 with DBH (3 eq.)/Py.9HF (6 eq.) generated a complex reaction mixture. These results reiterate the mechanistic assumption that ring activating groups (e.g., OMe) on the aryl ring promote the first fluorination step.
Moreover, treatment of α-fluorothioether 8 with DBH/Py.9HF at −78 °C effected selective bromination of the uracil ring at the C5 position52 yielding the corresponding 5-bromo derivative 9 as a major product (50%), however with no indication of the geminal difluoro product formation (Scheme 3). Interestingly, the α-fluoro thioether moiety in 9 remained intact under these oxidative conditions. It was previously noted that oxidation of α-fluoro thioethers to the α-fluoro sulfoxides with m-CPBA required higher temperature and longer reaction time than conversion of the unfluorinated thioethers to the corresponding sulfoxides.50
Since the oxidative desulfurization-fluorination approaches were not efficient protocols for the utilization of 2'-arylthiouridine derivatives as substrates for the modification of the C2'-position, we turned our attention to the development of a reductive desulfonylation approach. This strategy is consisted with the generation of an intermediary carbanion at the C2'-position of uridine derivatives which could be subsequently coupled to an electrophile (e.g., II; Figure 1). We assumed that such anion could be obtained through cleavage of the C2'-S bond in 2'-arylsulfonyl-2'-deoxyuridine substrates. Moreover, such sulfones derivatives could be conveniently synthesized by simple oxidation of the arylthiouridine substrates used for the oxidative approach.50,51 Reductive removal of sulfones is usually mediated by highly aggressive metal-containing reducing agents, typically alkali metals, not always compatible with the nucleoside chemistry, as they can cause side reactions on the diverse functional groups present in the molecule.33 Instead, we opted for the use of recently reported organic electron donors (OEDs)55-57 that can selectively cleave C-SO2 bonds by stepwise transfer of two electrons under mild reaction conditions.35,58 The bispyridinylidene SED has a redox potential of E1/2 (DMF)= − 1.24 V vs SCE (Figure 2) and efficiently reduces sulfones via the formation of anion intermediates.58 Its high tolerance to other functional groups, such as ketones, made it particularly suitable for our 2'-deoxyuridine substrates.
Figure 2.
Redox potential and equilibria of bispyridinylidene SED named as “Super-electron donor”.
When the 2'-sulfone 1050 was treated at r.t. with the organic reductant SED, the reaction cleanly provided the furan product 11 in 95% yield after 15 min (Scheme 4). The uracil base 12 was identified (but not isolated) by 1H NMR in the aqueous phase along with other impurities. To our surprise, cleavage of the C2'-S bond was not observed and the unexpected formation of 11 could not be explained by a sole electron-transfer mechanism. To rationalize this result, we tried the same reaction with a less powerful organic reductant, the commercially available tetrakis(dimethylamino)ethylene (TDAE) [E1/2 (DMF) = −0.62 V vs SCE]. Treatment of 2'-sulfone 10 with an excess of TDAE gave the 3'-acetoxy elimination product 13 (34%), the enol type (open chain sugar) product 14 (20%) and the same furan derivative 11 (46%).
Scheme 4.
Reduction studies of the acetyl-protected sulfone substrate 10 with organic donors.
Cyclic voltammetry analysis showed that sulfone derivative 10 could be reduced in two irreversible reduction steps at potentials of − 2.42 and − 2.64 V vs SCE (Figure S1, Table S1, Supporting Information), with the first reduction step (Epc1) corresponding to the cleavage of the C2'-S bond with the expulsion of the p-methoxybenzenesulfinate. This hypothesis was confirmed by the cyclic voltammetry of an authentic sample59 of sodium p-methoxybenzenesulfinate (Figure S2). While the reduction potential is in the array of redox potentials that the effective reducing power of SED could reportedly attain,60 the redox potential gap between TDAE and 10 (ΔE > 1.2 V) clearly indicates that reduction of 10 cannot be achieved by TDAE-promoted electron transfer. Since OEDs can act as base or as reducing agent,61,62 we assumed that TDAE initially acted as a base inducing elimination of AcOH by abstracting H2' to produce 13 (Scheme 5). Judging from the first reduction potential of 13 (Epc1 = − 2.11 V vs SCE; Table S1, Figure S3), further reduction of 13 by TDAE to produce 11 would also be rather difficult. One can think that TDAE is only acting as a base and that 13 suffers from base-induced reactions leading in turn to 14 and 11 (base-induced pathway, Scheme 5). The hypothesis of a basic behavior was supported by the fact that reaction of 10 with 4-dimethylaminopyridine (DMAP) led to the quantitative formation of 11. On the other hand, in the case of SED, a mixed base-/electron transfer-induced mechanism could occur and rapidly lead to 11. We assumed that under more forced reducing conditions,60 13 could be reduced in parallel to the base-induced reactions (ET-induced pathway, Scheme 5). Hence, 13 could be reduced by single-electron transfer (SET) leading to glycosidic bond cleavage, followed by trapping of the formed radical by the radical cation of the electron donor (SED•+).63 A last base-induced reaction would give 11 and regenerate the SED.
Scheme 5.
Proposed "base-versus electron transfer-induced" mechanism for the reaction of 10 with OEDs.
Since the acetyl protection in 10 was base labile in the presence of OEDs, and prone to elimination from the intermediate C2'-carbanion, we also studied benzylated sulfone substrates. However, treatment of the fully benzylated 2'-[(4-methoxyphenyl)sulfonyl]uridine 1551 (Epc1 = − 2.42 V vs SCE; Figure S1, Table S1) with a stoichiometric amount of SED resulted in a similar rapid glycosidic bond cleavage producing the vinyl sulfone 16 (70%) and 3-N-benzyluracil 17 (69%; Scheme 6). This result indicated that the basic character of SED was probably predominant over its reducing character with substrates bearing a labile α-hydrogen. Treatment of 15 with an excess of SED gave two inseparable ribose derivatives: the vinyl sulfone 16 and the furan derivative 18 with possibly the latter being formed from 16 under reducing and/or basic conditions as proposed for 10 in Scheme 5.
Scheme 6.
Reduction studies of benzyl protected sulfone substrate 15 with the SED
Since the α-hydrogen of 2'-sulfone substrates were too labile under the desired reductive conditions, α-fluorosulfones 1950 and 2451 were chosen for the further studies. Thus, treatment of α-fluorosulfone 19 (Epc1 = − 2.36 V vs SCE; Figure S4, Table S1) with the SED reagent at room temperature gave the mono 3’-deacetylated product 20 (45% conversion) along with unchanged starting material but no further degradation or glycosidic bond cleavage were observed (Scheme 7).64 The reduction of the sulfonyl moiety was not observed at this temperature. However, known fluorovinyl compound 2165 was obtained in 46% yield when 19 was treated with 3 eq. of SED at 120 °C. This result indicated that reductive cleavage of the sulfone took place with excess SED at high temperature. Controlled-potential electrolysis of 19 in DMF at − 1.90 V vs SCE, a potential more positive to the first potential peak measured by cyclic voltammetry (see Table S1), gave, after the consumption of 2.0 F/mole of substrate (1 h, r.t), a main fraction that contained 21 and 19 as an inseparable mixture (ratio ~ 8:2), with estimated yield of 21 close to 45% (Scheme 7). Noteworthy to mention that 2'-deoxy-2'-fluoridine 22, the diacetylated 23 and uracil 12 (albeit in low amount) were also detected in the crude reaction mixture. These results were in line with the profile of products obtained with an excess of the SED reagent at 120°C/3h, however it offered an alternative milder approach to prepare 21 by a reductive approach. The results with SED or the electrochemical activation provided evidence that the C2' anion was indeed generated through C2'-S bond cleavage. It is important to note that replacement of SED with other reducing agents such as samarium iodide did not affect the reduction of the sulfonyl moiety.
Scheme 7.
Reactivity studies of acetyl protected α-fluorosulfone 19 with OED and under electrochemical activation.
To avoid the elimination of the acetate anion from C3' position, the benzyl protected 2'-α-fluorosulfone derivative 24 was employed to study the reduction of the sulfone moiety with SED. However, treatment of 24 with SED under analogous conditions (3 equiv.; DMF, 120 °C, 3 h) produced a complex reaction mixture (Scheme 8), from which two major products were isolated: furan 25 and 3-N-benzyluracil 17. Also observed by LC-MS was trace amounts of sulfone cleavage product 26, providing again evidence of the C2'-anion generation, trapped by proton abstraction. Intriguingly, in the furan derivative 25, sulfone moiety was present and elimination of fluorine was observed. Furan derivative 25 could have been formed from either the reduction of the glycosidic bond followed by base induced fluoride elimination or vice versa. Analogous treatment of 24 with SED at room temperature gave only trace amounts of 25 and 17 along with unchanged starting material. Reaction in the presence of deoxygenated water at 80 °C, in order to favour the formation of reduction product 26 (to enhance proton abstraction), did not change the outcome of the reaction. The elimination product 25 and 3-N-benzyluracil 17 were obtained in 80% and 60% isolated yields respectively.
Scheme 8.
Reactivity studies of benzyl protected α-fluorosulfone 24 with SED and under electrochemical activation.
Controlled-potential electrolysis of 24 in DMF at − 2.20 V vs SCE, a potential slightly less positive to the first peak potential measured by cyclic voltammetry (see Table S1), gave, after the consumption of 2.1 F/mole of substrate (1 h, r.t), 17 in 74% isolated yield and an inseparable mixture containing 24 and 26 (ratio ~ 2.5:1) with also additional products. The estimated yield of 26 was roughly 18%, a yield slightly higher compared to the reaction using the SED reagent (Scheme 8). Although the electrolysis did not go to complete conversion of starting material, as opposed to the results obtained with the SED reagent, there was no indication of formation of furan 25. The electrochemical reductive cleavage of 24 seems to be more complex than 19 since generation of more products was observed, but formation of 22, 23 and 26 under milder electrochemical conditions, is again an attractive starting point for further optimization studies and possible anion trapping.
Conclusion
In conclusion, new methods for the modification of nucleosides at the C2'-position via oxidative and reductive activation of carbon-sulfur bonds in readily available 2'-thionucleosides were studied. The oxidative desulfurization-difluorination of aryl-alkyl thioethers including 2'-S-aryl-2'-thiouridine substrates, using the protocol of Haufe et al. was studied with mixed results. Although successful on 2-(arylthio)alkanoate surrogates, combination of oxidants and fluoride sources was not an efficient fluorination protocol when applied to 2'-thiouridine derivatives, resulting mainly in C5-halogenation of the pyrimidine ring and C2'-monofluorination without desulfurization. Our reductive desulfonylation approach using Organic Electron Donors (OEDs) was hampered by competitive base-induced mechanisms in the case of substrates bearing a labile α-hydrogen, resulting in the elimination of the uracil moieties. On the other hand, reduction of α-fluorosulfone derivatives with OED or by electrochemical activation provided good evidence that the C2'-anion was indeed generated through C2'-S bond cleavage. The major benefit of the electrochemical activation was the milder conditions of the protocol (r.t., no base, short time) leading to the formation of 2',3'-unsaturated-2'-fluorouridine and 2'-fluorinated products. These results open new horizons for the reductive desulfonylation-functionalization strategies, which, although, are still not fully developed in nucleosides, have the potential to be utilized in the synthesis of highly substituted nucleoside analogues including C2'-difluoro analogues.
Experimental Section
Reagent grade chemicals were used and solvents were dried by reflux and distillation from CaH2 under N2 unless otherwise specified, and an atmosphere of N2 was used for reactions. The MBraun glovebox used for some reactions contained dry argon and less than 1 ppm oxygen and water. Reaction progress was monitored by TLC on Merck Kieselgel 60-F254 sheets with product detection by 254-nm light. Products were purified by column chromatography using Merck Kiselgel 60 (230-400 mesh) or by automated flash chromatography using a CombiFlash system. UV spectra were recorded with a Varian Cary 100 Bio UV-visible spectrophotometer. 1H (400 MHz), 13C (100.6 MHz), and 19F (376 MHz) NMR spectra were recorded at ambient temperature in solutions of CDCl3 or DMSO-d6. MS and HRMS spectra were recorded in ESI+ or ESI-mode, unless otherwise noted. The bispyridinylidene SED was synthesized following reported procedure,58 stored in a glove box and used as a well-defined dark purple solid.
Electrochemical measurements were performed using an EG & G-Princeton Applied Research 263A all-in-one potentiostat, using a standard three-electrode setup with a glassy carbon electrode (working electrode, diameter = 3 mm), platinum wire auxiliary electrode and a non-aqueous Ag/Ag+ (0.01M AgNO3 + 0.1M n-Bu4NClO4) system in MeCN as the reference electrode. All solutions under the study were 0.1 M in the supporting electrolyte n-Bu4NPF6 (Fluka, electrochemical grade) with the voltage scan rate of 0.2 V s−1. Solutions (2.5 mL) were thoroughly bubbled with dry Ar for 15 min to remove oxygen before any experiment and kept under positive pressure of Ar. Under these experimental conditions the ferrocene/ferricinium couple, used as internal reference for potential measurements, was located at E1/2 = + 0.05 V in DMF. Controlled-potential electrolyses were run in a cylindrical divided cell (see Figure S5) using a porous reticulous carbon electrode (S ~ 2.5 cm2) as working electrode, a platinum wire as counter electrode separated from the cathodic compartment with a frit glass (porosity 4) and Ag wire as a pseudo reference. Cyclic voltamograms were recorded before the electrolysis and during the electrolysis using a glassy carbon electrode (diameter = 1 mm). The solutions containing the substrate and the supporting electrolyte (n-Et4NBF4 0.1 M) were thoroughly bubbled with dry Ar for 15 min to remove oxygen before any experiment and kept under positive pressure of Ar.
Ethyl 2-(phenylthio)octanoate (2)
Thiophenol (260 μL, 280 mg, 2.54 mmol) was added to a stirred solution of NaH (60%, dispersion in paraffin liquid; 100.4 mg, 4.18 mmol) in anhydrous DMF (4 mL) at 0 °C. The resulting suspension was stirred at 0 °C for 30 min and at ambient temperature for 30 min, until bubbling (H2 gas) ceased. The reaction flask was chilled again and ethyl 2-bromooctanoate (540 μL, 630 mg, 2.51 mmol) was added at 0 °C. The resultant clear, colorless solution was stirred at 0 °C for 20 min and at ambient temperature for 2 h, by which time TLC showed exclusive conversion to a slightly more polar spot. Volatiles were evaporated and co-evaporated with toluene (1 ×) (vacuum pump) and the resulting pale gum was partitioned between CHCl3 (20 mL) and NH4Cl/H2O (20 mL). The aqueous layer was extracted with CHCl3 (2 × 5 mL) and the combined organic phase was washed with NaHCO3/H2O (25 mL), brine (25 mL), and dried (MgSO4). Volatiles were evaporated in vacuo and the residue was column chromatographed (10% EtOAc in hexanes) to give 266 (633 mg, 90%) as a pale oil: 1H NMR (CDCl3) δ 7.49-7.46 (m, 2H, Ph), 7.35-7.25 (m, 3H, Ph), 4.16-4.09 (m, 2H, CH2), 3.66 (dd, J = 6.6, 8.4 Hz, 1H, H2), 1.96-1.87 (m, 1H, H3), 1.82-1.73 (m, 1H, H3'), 1.51-1.37 (m, 2H, H4, H4'), 1.36-1.26 (m, 6H, H5, H5', H6, H6', H7, H7'), 1.19 (t, J = 7.1 Hz, 3H, CH3), 0.90 (“t”, J = 6.8 Hz, 3H, CH3); 13C NMR (CDCl3) δ 172.4, 133.8, 132.7, 128.9, 127.7, 61.0, 50.9, 31.7, 31.5, 28.8, 27.2, 22.5, 14.1, 14.0.
Ethyl 2-((4-chlorophenyl)thio)hexanoate (3)
Treatment of ethyl 2-bromohexanoate (500 μL, 610.5 mg, 2.74 mmol) with 4-chlorothiophenol/NaH/DMF, as described for 2, gave 367 as a pale yellow oil (763.6 mg, 97%): 1H NMR (CDCl3) δ 7.41-7.37 (m, 2H, Ph), 7.30-7.26 (m, 2H, Ph), 4.17-4.09 (m, 2H, CH2), 3.61 (dd, J = 6.6, 8.4 Hz, 1H, H2), 1.94-1.84 (m, 1H, H3), 1.81-1.69 (m, 1H, H3'), 1.51-1.27 (m, 4H, H4, H4', H5, H5'), 1.19 (t, J = 7.1 Hz, 3H, CH3), 0.91 (“t”, J = 7.1 Hz, 3H, CH3); 13C NMR (CDCl3) δ 172.1, 134.11, 134.10, 132.1, 129.0, 61.1, 51.0, 31.3, 29.4, 22.2, 14.1, 13.8.
Ethyl 2-((4-methoxyphenyl)thio)hexanoate (4)
Treatment of ethyl 2-bromohexanoate (500 μL, 610.5 mg, 2.74 mmol) with 4-methoxythiophenol/NaH/DMF, as described for 2, gave 468 as a colorless oil (739.3 mg, 96%): 1H NMR (CDCl3) δ 7.36-7.31 (m, 2H, Ph), 6.78-6.74 (m, 2H, Ph), 4.02 (“q”, J = 7.2 Hz, 2H, CH2), 3.41 (dd, J = 6.6, 8.5 Hz, 1H, H2), 1.82-1.75 (m, 1H, H3), 1.68-1.59 (m, 1H, H3'), 1.42-1.32 (m, 1H, H4), 1.30-1.21 (m, 3H, H4', H5, H5'), 1.10 (t, J = 7.1 Hz, 3H, CH3), 0.82 (t, J = 7.1 Hz, 3H, CH3); 13C NMR (CDCl3) δ 172.2, 160.1, 136.2, 123.4, 114.4, 60.7, 55.2, 51.6, 31.1, 29.3, 22.3, 14.1, 13.8.
General procedure for the preparation of ethyl difluoroalkanoates (5)
DBH (1.5 mmol) was added to a stirred solution of esters 2 or 3 or (0.5 mmol) and Py.9HF (3 mmol) in CH2Cl2 (2 mL) in a polypropylene vessel at ambient temperature. The resulting brown solution was stirred at 35 °C for 2 h (2), 1 h (3) or 16 h (4). The reaction flask was cooled to room temperature, quenched by addition of ice-cold water, diluted with CH2Cl2, and neutralized with drop-wise addition of conc. NH4OH. Organic layer was separated and aqueous layer was back extracted (2 × CH2Cl2). Combined organic layer was washed with 1N HCl, brine, dried (MgSO4) and concentrated in vacuo to give crude difluorinated product 5b (95% conversion from 2) or 5a (95% conversion from 3; 70% conversion from 4) as a brown oil, with data as reported.69
5a69 had: 1H NMR (CDCl3) δ 4.25 (q, 3JH,H = 7.2 Hz, 2H, CH2), 2.09-1.88 (m, 2H, H3, H3'), 1.42-1.30 (m, 4H, H4, H4', H5, H5'), 1.28 (t, 3JH,H = 7.1 Hz, 3H, CH3), 0.85 (t, 3JH,H = 7.2 Hz, 3H, H6, H6', H6"); 13C NMR (CDCl3) δ 164.4 (t, 2JF,C = 33.2 Hz, C1), 116.4 (t, 1JF,C = 249.8 Hz, C2), 63.0 (CH2), 34.5 (t, 2JF,C = 23.2 Hz, C3), 23.5 (t, 3JF,C = 4.3 Hz, C4), 22.2 (C5), 13.9 (CH3), 13.7 (C6); 19F NMR (CDCl3) δ −105.92 ppm (t, 3JF-H = 16.8 Hz); GC-MS (tR = 7.5 min) 151 (M+-Et, 1.1), 87 (100).
5b69 had: 1H NMR (CDCl3) δ 4.25 (q, 3JH,H = 7.2 Hz, 2H, CH2), 2.03-1.91 (m, 2H), 1.45-1.18 (m, 11H), 0.81 (“t”, 3JH,H = 6.8 Hz, 3H, H6, H6', H6"); 13C NMR (CDCl3) δ 164.5 (t, 2JF,C = 33.0 Hz, C1), 116.4 (t, 1JF,C = 249.7 Hz, C2), 62.7 (CH2), 34.5 (t, 2JF,C = 23.2 Hz, C3), 31.4, 28.7, 22.4, 21.4 (t, 3JF,C = 4.3 Hz, C4), 13.9; 19F NMR (CDCl3) δ −105.89 ppm (t, 3JF-H = 17.0 Hz); GC-MS (tR = 7.4 min) 179 (M+-Et, 60.8), 144 (100).
3-N-benzyl-3',5'-di-O-benzyl-5-iodo-2'-S-(4-methoxyphenyl)-2'-thiouridine (7) and 3-N-benzyl-3',5'-di-O-benzyl-2'-fluoro-2'-S-(4-methoxyphenyl)-2'-thiouridine (8). NIS (95 mg, 0.42 mmol) was added to a stirred solution of 6 (128 mg, 0.2 mmol) and Py.9HF (138 μL, 0.6 mmol) in anhydrous CH2Cl2 (3 mL) at −78 °C in a polypropylene vessel and the resulting brown solution was brought to ~5 °C overnight (16 h). Stirring was continued at ambient temperature for 7 h (total reaction time: 23 h). The reaction was quenched by addition of ice-cold water (10 mL), diluted with CH2Cl2 (5 mL), neutralized with drop-wise addition of conc. NH4OH. Organic layer was separated and aqueous layer was back extracted (2 × CH2Cl2). Combined organic layer was washed with 1N HCl (10 mL), brine (10 mL), dried (MgSO4), and filtered. Volatiles were evaporated in vacuo and the brown residue was column chromatographed (5% → 20% EtOAc in hexanes) to give 7 (44 mg, 29%) as a colorless oil and 851 (2'-R/S-S, ~ 1:1; 16 mg, 12%) as a pale-yellow oil.
7 had: UV (MeOH) λmax 253, 283 nm, λmin 246, 273 nm; 1H NMR (CDCl3) δ 7.66-7.63 (m, 2H, Ph), 7.56 (s, 1H, H6), 7.44-7.31 (m, 13H, Ph), 7.12-7.10 (m, 2H, Ph), 6.51 (d, J = 8.9 Hz, 1H, H1'), 6.33-6.30 (m, 2H, Ph), 5.15 (“d”, J = 13.4 Hz, 1H, benzylic), 5.02 (“d”, J = 13.3 Hz, 1H, benzylic), 4.68-4.52 (m, 4H, benzylic), 4.33-4.25 (m, 2H, H4', H3'), 3.76-3.67 (m, 2H, H2', H5'), 3.66 (s, 3H, OCH3), 3.51 (dd, J = 2.0, 10.5 Hz, 1H, H5"); 13C NMR (CDCl3) δ 159.8, 159.1, 150.8, 142.2 (C6), 137.22, 137.16, 136.2, 135.2, 130.4, 128.8, 128.6, 128.4, 128.2, 128.1, 128.06, 127.8, 127.7, 123.0, 114.7, 90.2 (C1'), 82.1 (C3'), 80.7 (C4'), 73.8 (CH2), 72.3 (CH2), 70.5 (C5), 68.9 (C5'), 56.4 (C2'), 55.5 (OCH3), 46.0 (CH2). HRMS (ESI) m/z 785.1119 [M+Na]+, calcd for C37H35IN2NaO6S+ 785.1133.
Analogous treatment of 6 (128 mg, 0.2 mmol) with NIS (95 mg, 0.42 mmol) and DAST (160 μL, 1.2 mmol) followed by aqueous workup (sat. Na2S2O3, sat. NaHCO3, brine, MgSO4) and column chromatography gave 851 (2'-R/S-S, ~ 1:1; 58 mg, 44%) as a pale-yellow oil.
3-N-benzyl-3',5'-di-O-benzyl-5-bromo-2'-fluoro-2'-S-(4-methoxyphenyl)-2'-thiouridine (9)
Py.9HF (62 μL, 0.27 mmol) was added to a chilled solution of DBH (19 mg, 0.066 mmol) in dry CH2Cl2 (1 mL) at −78 °C. The resulting pale solution was stirred at −78 °C for 10 min and a solution of substrate 8 (40 mg, 0.06 mmol) in dry CH2Cl2 (2 mL) was added via syringe. The resultant orange solution was stirred at −78 °C for 2 h and was brought to −30 °C over 45 min. The reaction mixture was diluted with CH2Cl2 (5 mL), washed with NaHCO3/H2O (5 mL), H2O (5 mL), brine (5 mL), dried (MgSO4). Volatiles were evaporated in vacuo and the yellow residue was column chromatographed (15% EtOAc in hexanes) to give 9 as mixture of diastereomers (2'-R/S-S, ~ 4:1) (pale-yellow oil, 22 mg, 50%): UV (MeOH) λmax 253, 280 nm, λmin 239, 271 nm; 1H NMR (CDCl3) δ 7.84 (s, 1H, H6), 7.81 (d, J = 2.1 Hz, 0.2H, Ph), 7.66 (d, J = 2.2 Hz, 0.8H, Ph), 7.49-7.23 (m, 17H, Ph), 6.78 (d, J = 8.7 Hz, 0.8H, Ph), 6.75 (d, J = 8.7 Hz, 0.2H, Ph), 6.44 (d, J = 13.9 Hz, 0.8H, H1'), 6.27 (br s, 0.2H, H1'), 5.09 (“d”, J = 13.6 Hz, 1H, benzylic), 4.92-4.80 (m, 1H, benzylic), 4.73-4.65 (m, 1H, benzylic), 4.62-4.41 (m, 3H, benzylic), 4.18-4.09 (m, 2H, H3', H4'), 3.92 (s, 0.6H, CH3), 3.91 (s, 2.4H, CH3), 3.82-3.72 (m, 1H, H5'), 3.61-3.53 (m, 1H, H5"); 19F NMR (CDCl3) δ −133.52 ppm (br s, 0.8F), −131.57 ppm (br s, 0.2F); 13C NMR (CDCl3) for major isomer: δ 158.4, 157.2, 149.4, 138.1, 137.79, 137.76, 137.3, 136.8, 135.9, 134.1, 134.0, 129.3, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 120.24, 120.23, 112.2, 112.0, 108.7 (d, 1JC2'-F = 239.1 Hz, C2'), 96.9, 90.4 (d, 2JC1'-F = 47.3 Hz, C1'), 80.3 (C4'), 79.7 (d, 2JC3'-F = 17.7 Hz, C3'), 73.5 (CH2), 73.1 (CH2), 67.0 (C5'), 56.4 (OCH3), 45.7 (CH2). HRMS (ESI) m/z 755.1182 [M+Na]+, calcd for C37H3479Br2FN2NaO6S+ 755.1197.
5'-O-Acetyl-2',3'-dideoxy-2',3'-didehydro-2'-[(4-methoxyphenyl)sulfonyl]uridine (13), 1-[5-acetyl-4-hydroxy-2-((4-methoxyphenyl)sulfonyl)-1,3-pentadien-1-yl]uracil (14) and [4-[(4-methoxyphenyl)sulfonyl]furan-2-yl]methyl acetate (11)
TDAE (0.24 mL, 1.04 mmol) was added to a stirred solution of 10 (100 mg, 0.207 mmol) in anhydrous DMF (2 mL) at −78 °C under argon. The reaction mixture was brought to ambient temperature over 1 h 15 min and a 10% HCl solution (2 mL) was then added. The crude was extracted with EtOAC (3 ×) and the combined organic phase was dried over anhydrous Na2SO4. Volatiles were evaporated in vacuo and the residue was column chromatographed (PE 100% → EtOAc/PE 2/1 → EtOAc 100%) to give 11 (29.5 mg, 46%), 14 (17.5 mg, 20%), and 13 (30 mg, 34%), all as colorless oils.
13 had: 1H NMR (CDCl3) δ 9.23 (br, 1H, NH), 7.79-7.75 (m, 2H, Ph), 7.24 (d, J = 8.4 Hz, 1H, H6), 7.18 (t, J = 1.6 Hz, 1H, H3’), 7.03-6.99 (m, 3H, Ph, H1'), 5.55 (dd, J = 2, 8.4 Hz, 1H, H5), 5.12-5.09 (m, 1H, H4'), 4.41 (dd, J = 4, 12.4 Hz, 1H, H5'), 4.29 (dd, J = 3.6, 12.4 Hz, 1H, H5"), 3.87 (s, 3H, OCH3), 2.09 (s, 3H, Ac); 13C NMR (50 MHZ, CDCl3) δ 170.1 (C=O), 164.9 (CPh), 162.9 (C4), 150.3 (C2), 142.1 (C6), 141.9 (C2'), 139.5 (C3'), 130.8 (CHPh), 129.1 (CPh), 115.2 (CHPh), 103.2 (C5), 87.5 (C1'), 82.8 (C4'), 63.9 (C5'), 56.1 (OCH3), 20.8 (Ac). HRMS (ESI) m/z 423.0856 [M+H]+, calcd for C18H19N2O8S+ 423.0857.
14 had: 1H NMR (CDCl3) δ 9.00 (br s, 1H, NH), 7.76 (d, J = 8.8 Hz, 2H, Ph), 7.58 (s, 1H, H1'), 6.97-6.99 (m, 3H, Ph, H6), 5.69 (br, 1H, OH), 5.62 (dd, J = 1.2, 8.0 Hz, 1H, H5), 4.93-4.79 (m, 1H, H3'), 4.27 (dd, J = 4.4, 12.4 Hz, 1H, H5'), 4.21 (dd, J = 4.8, 12.4 Hz, 1H, H5"), 3.86 (s, 3H, OCH3), 1.95 (s, 3H, Ac); 13C NMR (CDCl3) δ 170.4 (C=O), 164.2 (CPh), 162.6 (C4), 160.3 (C1'), 150.3 (C2), 140.2 (broad, C6), 131.5 (CPh), 129.9 (CHPh), 116.9 (broad, C2’), 114.9 (CHPh), 103.7 (C5), 88.7 (broad, C3'), 63.4 (C5'), 55.6 (OCH3), 20.5 (CH3AC). HRMS (ESI) m/z 423.0864 [M+H]+, calcd for C18H19N2O8S+ 423.0857; 440.1119 [M+NH4]+, calcd for C18H22N3O8S+ 440.1122.
11 had: 1H NMR (CDCl3) δ 7.93 (d, J = 0.8 Hz, 1H, H1), 7.85-7.89 (m, 2H, Ph), 6.96-7.00 (m, 2H, Ph), 6.56 (s, 1H, H3), 4.97 (s, 2H, H5, H5'), 3.85 (s, 3H, OCH3), 2.05 (s, 3H, Ac); 13C NMR (CDCl3) δ 170.3 (C=O), 163.8 (CPh), 152.4 (C4), 145.7 (C1), 132.9 (C2), 131.1 (CPh), 129.8 (CHPh), 114.7 (CHPh), 108.7 (C3), 57.4 (C5), 55.8 (OCH3), 20.8 (CH3AC); HRMS (ESI) m/z 328.0852 [M+NH4] , calcd for C14H18NO6S+ 328.0849.
[4-[(4-Methoxyphenyl)sulfonyl]furan-2-yl]methyl acetate (11) and uracil (12)
In a glove box, SED (31 mg, 0.1 mmol) was added to a solution of 10 (50 mg, 0.1 mmol) in anhydrous DMF (4 mL) and the resulting mixture was stirred at ambient temperature for 15 min. Then the reaction flask was brought out of the glove box and water was added to the crude reaction mixture. The aqueous phase was extracted with CH2Cl2 (3 ×), the combined organic phase was dried over anhydrous Na2SO4 and volatiles were evaporated in vacuo to give 11 (29.4 mg, 95%) as a colorless oil.
Acidification of the aqueous phase (pH ~5-6) followed by extraction (2 × CH2Cl2) gave a white solid. 1H NMR (MeOD) of the white solid revealed the presence of uracil 12 along with other impurities.
3,5-di-O-Benzyl-1,2-dideoxy-1,2-didehydro-2-[(4-methoxyphenyl)sulfonyl]ribose (16), 2-[(benzyloxy)methyl]-4-[(4-methoxyphenyl)sulfonyl]furan (18) and 3-N-benzyluracil (17)
In a glove box, SED (22 mg, 7 × 10−5 mol, 1.05 equiv.) was added to a solution of 15 (45 mg, 6.7 × 10−5 mol) in DMF (4 mL) and the reaction mixture was stirred at ambient temperature for 15 min. Then the reaction flask was brought out of the glove box and water was added to the crude reaction mixture. The aqueous phase was extracted with CH2Cl2 (3 ×) and the combined organic phase was dried over anhydrous Na2SO4. Volatiles were evaporated in vacuo and the residue was column chromatographed (PE 100% → PE/EtOAc 9/1 → EtOAc 100%) to give 16 (22 mg, 70%) as a white gum and 17 (9.4 mg, 69%) as a white solid.
16 had: 1H NMR (CDCl3) δ 7.83-7.79 (m, 2H, Ph), 7.42 (s, 1H, H1), 7.37-7.31 (m, 3H, Ph), 7.26-7.24 (m, 5H, Ph), 7.09-7.07 (m, 2H, Ph), 6.86-6.84 (m, 2H, Ph), 4.86 (d, J = 3.2 Hz, 1H, H3), 4.77 (td, J = 3.2, 5.6 Hz, 1H, H4), 4.49 (d, J = 2.4 Hz, 2H, CH2), 4.40 (s, 2H, CH2), 3.81 (s, 3H, OCH3), 3.48 (dd, J = 5.6, 10.4 Hz, 1H, H5), 3.40 (dd, J = 5.6, 10.4 Hz, 1H, H5); 13C NMR (CDCl3) δ 163.3 (CPh), 159.7 (C1), 137.4 (CPh), 137.3 (CPh), 133.6 (CPh), 129.8 (2 CHPh), 128.7 (2 CHPh), 128.4 (2 CHPh), 128.1 (3 CHPh), 128.0 (CHPh), 127.9 (2 CHPh), 119.7 (C2), 114.2 (2 CHPh), 90.3 (C3), 80.7 (C4), 73.7 (CH2), 70.8 (CH2), 68.9 (C5), 55.7 (OCH3); HRMS (ESI) m/z 484.1789 [M+NH4]+, calcd for C26H30NO6S+ 484.1788.
Analogous treatment of 15 (50 mg, 7.5 × 10−5 mol) with SED (64 mg, 2.2 × 10−4 mol, 3 equiv.) in DMF (4 mL) for 30 min at room temperature gave 18 as a mixture with 16 (colorless oil; 7.4 mg; ratio of 16:18 is 33/67) and 17 (13 mg, 86%) as a white solid.
18 had: 1H NMR (200MHz, CDCl3) δ 7.93 (s, 1H, H1), 7.91-7.84 (m, 2H, Ph), 7.36-7.30 (m, 5H, Ph), 7.01-6.96 (m, 2H, Ph), 6.49 (s, 1H, H3), 4.53 (s, 2H, CH2), 4.42 (s, 2H, H5), 3.86 (s, 3H, OCH3); MS (ESI) m/z 376.17 [M+NH4]+, calcd for C19H22NO5S+ 376.12.
5'-O-Acetyl -2',3'-didehydro-2',3'-dideoxy-2'-fluorouridine (21)
In a glove box, SED (68 mg, 0.24 mmol, 3 equiv.) was added to a stirred solution of 19 (40 mg, 0.08 mmol) in anhydrous DMF (4 mL) and the resulting dark brown solution was stirred at 120 °C for 18 h. Reaction flask was brought out of the glove box, and 10% HCl solution was added to the crude reaction mixture. Aqueous layer was extracted with CH2Cl2 (2 ×). Combined organic layer was dried (Na2SO4), filtered, and concentrated in vacuo to give a brown solid. Et2O was added to the solid and was filtered. Filtrate was concentrated in vacuo to give 21 (<10 mg, ~46%) along with other impurities. 1H NMR of the black solid (DMSO-d6) showed similar peaks to the ones obtained for the oxidized form of the SED (SED2+).58
2165 had: 1H NMR (CDCl3) δ 8.47 (br s, 1H, NH), 7.52 (dd, J = 1.0, 8.1 Hz, 1H, H6), 6.90-6.88 (m, 1H, H1'), 5.78 (d, J = 8.1 Hz, 1H, H5), 5.69 (m, 1H, H3'), 5.06-5.02 (m, 1H, H4'), 4.35-4.21 (m, 2H, H5',5"), 2.11 (s, 3H, Ac); 19F NMR (CDCl3) δ −133.76 (t, J = 4.6 Hz, F2'); MS (EI) m/z 271.09 [M+H]+, calcd for C11H12FN2O + 271.07.
3-(Benzyloxy)-2-[(benzyloxy)methyl]-4-[(4-methoxyphenyl)sulfonyl]furan (25)
In a glove box, SED (62 mg, 0.22 mmol, 3 equiv.) was added to a solution of 24 (50 mg, 7.3 × 10−5 mol) in anhydrous DMF (4 mL) and the resulting solution was stirred at 120 °C for 3 h. Reaction flask was brought out of the glove box, and water was added to the crude reaction mixture. The aqueous phase was extracted with CH2Cl2 (3 ×) and the combined organic phase was dried with Na2SO4. Volatiles were evaporated in vacuo and the residue was column chromatographed (PE/EtOAc 9/1 → EtOAc 100%) to give 25 (19.6 mg, 58%) as a white gum and 3-N-benzyluracil (17; 12.4 mg, 84%) as white solid.
Analogous treatment, in a glove box, of 24 (58.3 mg, 8.5 × 10−5 mol) with SED (72 mg, 0.25 mmol, 3 equiv.) at ambient temperature for 4 h showed only trace amounts of 25 and 17 on TLC. Addition of degassed water (0.5 mL, 500 mg, 27.75 mmol) followed by heating at 80 °C for 30 min gave, after workup and silica gel chromatography, 25 (31.7 mg, 80%) and 17 (10.1 mg, 60%).
25 had: 1H NMR (200MHz, CDCl3) δ 7.94-7.87 (m, 2H, Ph), 7.83 (s, 1H, H1), 7.37-7.24 (m, 10H, Ph), 6.95-6.88 (m, 2H, Ph), 5.07 (s, 2H, CH2), 4.41 (s, 2H, CH2), 4.17 (s, 2H, CH2), 3.84 (s, 3H, OCH3); 13C NMR (50 MHz, CDCl3) δ 163.6 (C3), 144.8 (C1), 142.4 (CPh), 140.7 (CPh), 137.4 (CPh), 136.2 (CPh), 132.8 (C4), 130.0 (CHPh), 128.55(CHPh), 128.53 (CHPh), 128.48 (CHPh), 128.0 (CHPh), 127.9 (CHPh), 125.6 (C2), 114.3 (CHPh), 77.3 (CH2), 72.4 (CH2), 61.1 (CH2), 55.7 (OCH3). HRMS (ESI) m/z 482.1632 [M+NH4]+, calcd for C26H28NO6S+ 482.1632.
General procedure for the electrolysis of 19 and 24
Under argon was introduced in the cathodic compartment, 10 mL of an anhydrous DMF solution containing n-Et4NBF4 0.1M and 2.5 mL of the same solution in the anodic compartment (see Figure S6 for the cell). The cathodic solution was deoxygenated with argon bubbling for 15 min and then were introduced 19 or 24. Solution was stirred and deoxygenated further for 10 min. A cyclic voltamogram was then recorded using a glassy carbon electrode in order to determine the reduction potential of starting material. A constant potential of − 2.21 V for 19 or − 2.51 V for 24 was then applied at room temperature, with an itinital current close to 12-18 mA. The progress of the electrolysis was followed by cyclic voltammetry. After 2.0-2.1F/mole of starting material (1 h), the electrolysis was stopped and quenched with an aqeous NH4Cl solution and extracted with EtOAc (3 ×), the combined organic phase were washed with H2O (3 ×), dried over Na2SO4 and filtered. Concentration under vacuo left a residue that was purified by silica gel chromatography.
From 0.09 g (0.180 mmol) of 19, 75.1 mg of a viscous yellow oil was obtained as a crude product. Column chromatography (5% MeOH in CHCl3) gave a fraction (31.2 mg) that contained an inseparable mixture of 21 and 19 (ratio 8:2) with estimated yields of 21 (45%) and 19 (6%) from 1H- and 19F-NMR. Further elution gave traces amount of 22 and 23 along with other fluorinated impurities as confirmed by mass spectrometry and NMR.
From 0.09 g (0.131 mmol) of 24, 89.6 mg of a viscous yellow oil was obtained as crude product. Column chromatography (5% MeOH in CHCl3) gave a fraction (50 mg) that contained an inseparable mixture of 24 and 26 (ratio ~ 2.5:1) with estimated yields of 24 (43%) and 26 (18%) from 1H- and 19F-NMR. Further elution gave 17 (74%) in addition to other fluorinated impurities.
Supplementary Material
Acknowledgements
This investigation was supported by SC1CA138176 (NIH/NCI; SFW) award, Centre National de la Recherche Scientifique (CNRS) through “Action CNRS-USA n° 4020”, and Aix-Marseille and Claude Bernard Lyon 1 Universities. We also thank FIU Graduate School for the Dissertation Year Fellowship (RR), and NIH MARC U*STAR (GM083688-02) scholarship program (PT) as well as Romain Simon, Christian Duchet and Nathalie Enriques from the Centre Commun de Spectrométrie de Masse (CCSM) of Claude Bernard Lyon 1 Université, for the assistance and access to the mass spectrometry facility. JB, AGT, TT and PV express their thanks to Vincent Remusat and the Spectropole (Fédération des Sciences Chimiques de Marseille) for NMR and HRMS analyses.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Supplementary data
Supplementary data associated with this article can be found in the online version, at http://dx.doi.org/10.1016/j.tet.2016. These data include experimental procedures and characterization data for 2'-thiouridine precursors 6, 8, 15, and 24 as well as Table S1 and Figures S1-S5 for the cyclic voltammetry experiments with 10, 13, 15, 19 and 24.
References
- (1).Purser S, Moore PR, Swallow S, Gouverneur V. Chem. Soc. Rev. 2008;37:320. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]
- (2).Smart BE. J. Fluorine Chem. 2001;109:3. [Google Scholar]
- (3).Qiu X-L, Xu X-H, Qing F-L. Tetrahedron. 2010;66:789. [Google Scholar]
- (4).Hertel LW, Kroin JS, Misner JW, Tustin JM. J. Org. Chem. 1988;53:2406. [Google Scholar]
- (5).Gesto DS, Cerqueira NMFSA, Fernandes PA, Ramos MJ. Curr. Med. Chem. 2012;19:1076. doi: 10.2174/092986712799320682. [DOI] [PubMed] [Google Scholar]
- (6).Brown K, Dixey M, Weymouth-Wilson A, Linclau B. Carbohydr. Res. 2014;387:59. doi: 10.1016/j.carres.2014.01.024. [DOI] [PubMed] [Google Scholar]
- (7).Montgomery JA, Shortnacy-Fowler AT, Clayton SD, Riordan JM, Secrist JA., III J. Med. Chem. 1992;35:397. doi: 10.1021/jm00080a029. [DOI] [PubMed] [Google Scholar]
- (8).Bonate PL, Arthaud L, Cantrell WR, Jr., Stephenson K, Secrist JA, III, Weitman S. Nat. Rev. Drug Discovery. 2006;5:855. doi: 10.1038/nrd2055. [DOI] [PubMed] [Google Scholar]
- (9).Sofia MJ, Bao D, Chang W, Du J, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang P, Zhang H-R, Bansal S, Espiritu C, Keilman M, Lam AM, Steuer HMM, Niu C, Otto MJ, Furman PA. J. Med. Chem. 2010;53:7202. doi: 10.1021/jm100863x. [DOI] [PubMed] [Google Scholar]
- (10).Murakami E, Tolstykh T, Bao H, Niu C, Steuer HMM, Bao D, Chang W, Espiritu C, Bansal S, Lam AM, Otto MJ, Sofia MJ, Furman PA. J. Biol. Chem. 2010;285:34337. doi: 10.1074/jbc.M110.161802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Wilkinson JA. Chem. Rev. 1992;92:505. [Google Scholar]
- (12).Resnati G. Tetrahedron. 1993;49:9385. [Google Scholar]
- (13).Lal GS, Pez GP, Syvret RG. Chem. Rev. 1996;96:1737. doi: 10.1021/cr941145p. [DOI] [PubMed] [Google Scholar]
- (14).Tozer MJ, Herpin TF. Tetrahedron. 1996;52:8619. [Google Scholar]
- (15).Kirk KL. Org. Process Res. Dev. 2008;12:305. [Google Scholar]
- (16).Hugenberg V, Haufe G. J. Fluorine Chem. 2012;143:238. [Google Scholar]
- (17).Barth R, Rose CA, Schöne O. Top. Heterocycl. Chem. 2015:1–38. [Google Scholar]
- (18).Kuroboshi M, Kanie K, Hiyama T. Adv. Synth. Catal. 2001;343:235. [Google Scholar]
- (19).Sondej SC, Katzenellenbogen JA. J. Org. Chem. 1986;51:3508. [Google Scholar]
- (20).Hugenberg V, Haufe G. Synlett. 2009:106. [Google Scholar]
- (21).Hugenberg V, Wagner S, Kopka K, Schober O, Schaefers M, Haufe G. J. Org. Chem. 2010;75:6086. doi: 10.1021/jo100689v. [DOI] [PubMed] [Google Scholar]
- (22).Ayuba S, Fukuhara T, Hara S. Org. Lett. 2003;5:2873. doi: 10.1021/ol034912s. [DOI] [PubMed] [Google Scholar]
- (23).Fukuhara T, Hara S. Synlett. 2009:198. [Google Scholar]
- (24).Fukuhara T, Hara S. J. Org. Chem. 2010;75:7393. doi: 10.1021/jo101672g. [DOI] [PubMed] [Google Scholar]
- (25).Ayuba S, Yoneda N, Fukuhara T, Hara S. Bull. Chem. Soc. Jpn. 2002;75:1597. [Google Scholar]
- (26).Hara S, Monoi M, Umemura R, Fuse C. Tetrahedron. 2012;68:10145. [Google Scholar]
- (27).Shishimi T, Hara S. J. Fluorine Chem. 2014;168:55. [Google Scholar]
- (28).Fuchigami T, Mitomo K, Ishii H, Konno A. J. Electroanal. Chem. 2001;507:30. [Google Scholar]
- (29).Shen Y, Suzuki K, Atobe M, Fuchigami T. J. Electroanal. Chem. 2003;540:189. [Google Scholar]
- (30).Fuchigami T, Inagi S. Chem. Commun. 2011;47:10211. doi: 10.1039/c1cc12414e. [DOI] [PubMed] [Google Scholar]
- (31).Takahashi K, Inagi S, Fuchigami T. J. Electrochem. Soc. 2013;160:G3046. [Google Scholar]
- (32).Wnuk SF, Robins MJ. J. Am. Chem. Soc. 1996;118:2519. [Google Scholar]
- (33).Najera C, Yus M. Tetrahedron. 1999;55:10547. [Google Scholar]
- (34).Wnuk SF, Rios JM, Khan J, Hsu Y-L. J. Org. Chem. 2000;65:4169. doi: 10.1021/jo000342n. [DOI] [PubMed] [Google Scholar]
- (35).Schoenebeck F, Murphy JA, Zhou S-Z, Uenoyama Y, Miclo Y, Tuttle T. J. Am. Chem. Soc. 2007;129:13368. doi: 10.1021/ja074417h. [DOI] [PubMed] [Google Scholar]
- (36).Coeffard V, Thobie-Gautier T, Beaudet I, Le Grognec E, Quintard J-P. Eur. J. Org. Chem. 2008:383. [Google Scholar]
- (37).Senboku H, Nakahara K, Fukuhara T, Hara S. Tetrahedron Lett. 2010;51:435. [Google Scholar]
- (38).Viaud P, Coeffard V, Thobie-Gautier C, Beaudet I, Galland N, Quintard J-P, Le Grognec E. Org. Lett. 2012;14:942. doi: 10.1021/ol300003f. [DOI] [PubMed] [Google Scholar]
- (39).Xuan J, Li B-J, Feng Z-J, Sun G-D, Ma H-H, Yuan Z-W, Chen J-R, Lu L-Q, Xiao W-J. Chem. - Asian J. 2013;8:1090. doi: 10.1002/asia.201300224. [DOI] [PubMed] [Google Scholar]
- (40).Yang D-T, Meng Q-Y, Zhong J-J, Xiang M, Liu Q, Wu L-Z. Eur. J. Org. Chem. 2013;2013:7528. [Google Scholar]
- (41).Clive DLJ, Wickens PL, Sgarbi PWM. J. Org. Chem. 1996;61:7426. doi: 10.1021/jo9610570. [DOI] [PubMed] [Google Scholar]
- (42).Robins MJ, Lewandowska E, Wnuk SF. J. Org. Chem. 1998;63:7375. doi: 10.1021/jo981013m. [DOI] [PubMed] [Google Scholar]
- (43).Robins MJ, Wilson JS, Madej D, Low NH, Hansske F, Wnuk SF. J. Org. Chem. 1995;60:7902. [Google Scholar]
- (44).Amino Y, Iwagami H. Chem. Pharm. Bull. 1991;39:622. [Google Scholar]
- (45).Johansen O, Holan G, Marcuccio SM, Mau AWH. Aust. J. Chem. 1991;44:37. [Google Scholar]
- (46).Manchand PS, Belica PS, Holman MJ, Huang TN, Maehr H, Tam SYK, Yang RT. J. Org. Chem. 1992;57:3473. [Google Scholar]
- (47).Johansen O, Marcuccio SM, Mau AWH. Aust. J. Chem. 1994;47:1843. [Google Scholar]
- (48).Rayala R. Ph.D. Thesis. Florida International University; Miami: 2015. [Google Scholar]
- (49).Tomioka K, Ishiguro T, Iitaka Y, Koga K. Tetrahedron. 1984;40:1303. [Google Scholar]
- (50).Robins MJ, Mullah KB, Wnuk SF, Dalley NK. J. Org. Chem. 1992;57:2357. [Google Scholar]
- (51). Synthesis and spectroscopic data are described in supporting information.
- (52).Rayala R, Wnuk SF. Tetrahedron Lett. 2012;53:3333. doi: 10.1016/j.tetlet.2012.04.081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (53).Xu B, Unione L, Sardinha J, Wu S, Ethève-Quelquejeu M, Pilar Rauter A, Blériot Y, Zhang Y, Martín-Santamaría S, Díaz D, Jiménez-Barbero J, Sollogoub M. Angew. Chem. Int. Ed. 2014;53:9597. doi: 10.1002/anie.201405008. [DOI] [PubMed] [Google Scholar]
- (54).Chen H, Hu Z, Zhang J, Liang G, Xu B. Tetrahedron. 2015;71:2089. [Google Scholar]
- (55).Murphy JA. J. Org. Chem. 2014;79:3731. doi: 10.1021/jo500071u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (56).Doni E, Murphy JA. Chem. Commun. 2014;50:6073. doi: 10.1039/c3cc48969h. [DOI] [PubMed] [Google Scholar]
- (57).Broggi J, Terme T, Vanelle P. Angew. Chem., Int. Ed. 2014;53:384. doi: 10.1002/anie.201209060. [DOI] [PubMed] [Google Scholar]
- (58).Murphy JA, Garnier J, Park SR, Schoenebeck F, Zhou S.-z., Turner AT. Org. Lett. 2008;10:1227. doi: 10.1021/ol800134g. [DOI] [PubMed] [Google Scholar]
- (59).Liu J, Zhuang S, Gui Q, Chen X, Yang Z, Tan Z. Eur. J. Org. Chem. 2014;2014:3196. [Google Scholar]
- (60). Even transferring one electron from SED to the sulfone would theoretically appear difficult. Nevertheless, effective redox potentials of organic reducers in solution are much higher than their thermodynamic redox potential determined by electrochemical methods. It is explained by the formation of intimate charge-transfer complexes and ion pairing that eases the electron transfer. Additional π-π stacking between SED and nucleoside may help to form intimate complex and facilitate the reduction.
- (61).Hoffmann RW. Angew. Chem. Int. Ed. Engl. 1968;7:754. [Google Scholar]
- (62).Wiberg N. Angew. Chem. Int. Ed. Engl. 1968;7:766. [Google Scholar]
- (63).a) Fletcher RJ, Lampard C, Murphy JA, Lewis N. Trapping of radical species by the radical cation of the SED have already been observed. J. Chem. Soc., Perkin Trans 1. 1995:623. [Google Scholar]; b) Murphy JA, Schoenebeck F, Findlay NJ, Thomson DW, Zhou S-Z, Garnier J. J. Am. Chem. Soc. 2009;131:6475. doi: 10.1021/ja8092746. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Sword R, Baldwin LA, Murphy JA. Org. Biomol. Chem. 2011;9:3560. doi: 10.1039/c0ob01282c. [DOI] [PubMed] [Google Scholar]
- (64). Deacetylation is known to proceed under basic conditions. NH3/MeOH and amines are frequently used reagents.
- (65).Martin JA, Bushnell DJ, Duncan IB, Dunsdon SJ, Hall MJ, Machin PJ, Merrett JH, Parkes KEB, Roberts NA. J. Med. Chem. 1990;33:2137. doi: 10.1021/jm00170a015. [DOI] [PubMed] [Google Scholar]
- (66).Watanabe M, Ezoe Y, Isozaki M, Kasahara T, Hayashi S, Tamamura K. Proc. Sch. Sci. Tokai Univ. 1995;30:143. [Google Scholar]
- (67).Lau J, Kodra JT, Guzel M, Santosh KC, Mjalli AMM, Andrews RC, Polisetti DR. Novo Nordisk A/S, Den. WO 03/055482 A1. 2003 [Google Scholar]
- (68).Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R. J. Med. Chem. 2003;46:2361. doi: 10.1021/jm0205548. [DOI] [PubMed] [Google Scholar]
- (69).Yang ZY, Burton DJ. J. Org. Chem. 1992;57:5144. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









